Jefferies Financial Group Inc. Makes New $1.17 Million Investment in Revvity Inc. $RVTY

Posted by Brenda Bartman on May 29th, 2026

Jefferies Financial Group Inc. purchased a new position in shares of Revvity Inc. (NYSE:RVTY – Free Report) in the fourth quarter, Holdings Channel reports. The fund purchased 12,090 shares of the company’s stock, valued at approximately $1,170,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in RVTY. EdgePoint Investment Group Inc. increased its stake in shares of Revvity by 26.3% in the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock worth $751,536,000 after acquiring an additional 1,784,620 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Revvity by 127.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after acquiring an additional 980,142 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock valued at $186,307,000 after purchasing an additional 596,436 shares in the last quarter. Neuberger Berman Group LLC lifted its holdings in Revvity by 4,598.9% during the third quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock valued at $40,358,000 after purchasing an additional 450,648 shares in the last quarter. Finally, Diamond Hill Capital Management Inc. purchased a new position in Revvity during the third quarter valued at $35,206,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

Shares of RVTY stock opened at $100.73 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The firm’s 50-day moving average is $91.63 and its two-hundred day moving average is $97.18. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The company has a market capitalization of $11.24 billion, a PE ratio of 48.20, a price-to-earnings-growth ratio of 2.08 and a beta of 1.05.

Revvity (NYSE:RVTY – Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same period in the previous year, the firm earned $1.01 earnings per share. Revvity’s quarterly revenue was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts predict that Revvity Inc. will post 5.34 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is 13.40%.

Analyst Upgrades and Downgrades

RVTY has been the topic of several research reports. JPMorgan Chase & Co. decreased their price target on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. The Goldman Sachs Group decreased their price target on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. Stifel Nicolaus decreased their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Jefferies Financial Group raised their price target on shares of Revvity from $100.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday, February 2nd. Finally, Barclays raised their price target on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Four equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $107.73.

Check Out Our Latest Stock Report on Revvity

Revvity Company Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.